Page last updated: 2024-10-30

mebendazole and Pulmonary Eosinophilia

mebendazole has been researched along with Pulmonary Eosinophilia in 2 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piekarski, G1
Karnad, DR1
Meisheri, YV1

Other Studies

2 other studies available for mebendazole and Pulmonary Eosinophilia

ArticleYear
[Ascariasis. Causative agent: Ascaris lumbricoides hominis].
    Deutsche medizinische Wochenschrift (1946), 1980, Oct-10, Volume: 105, Issue:41

    Topics: Ascariasis; Child; Child, Preschool; Humans; Infant; Intestinal Obstruction; Levamisole; Mebendazole

1980
Mebendazole with levamisole in tropical pulmonary eosinophilia: an alternative in diethylcarbamazine allergy.
    Tropical doctor, 1992, Volume: 22, Issue:3

    Topics: Animals; Diethylcarbamazine; Drug Hypersensitivity; Drug Therapy, Combination; Filariasis; Humans; L

1992